Evidence map›Paper›PMID 39117907›Full record

ArticleNature microbiology2024

Author Correction: Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus.

Benjamin O Torres Salazar, Taulant Dema, Nadine A Schilling, Daniela Janek, Jan Bornikoel, Anne Berscheid, Ahmed M A Elsherbini, Sophia Krauss, Simon J Jaag, Michael Lämmerhofer and 9 more

Abstract readPublished Erratum
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Benjamin O Torres Salazar *Department of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Taulant Dema *Institute of Organic Chemistry, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-1932-2937
Nadine A SchillingCluster of Excellence EXC 2124 Controlling Microbes to Fight Infections, Tübingen, Germany.
Daniela JanekDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Jan BornikoelDepartment of Microbial Bioactive Compounds, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-9198-6025
Anne BerscheidGerman Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-1585-8715
Ahmed M A ElsherbiniDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0003-0267-4239
Sophia KraussDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Simon J JaagInstitute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-3847-774X
Michael LämmerhoferInstitute of Pharmaceutical Sciences, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-1318-0974
Min LiDepartment of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Norah AlqahtaniDepartment of Infection Biology and Microbiomes, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-8056-5057
Malcolm J HorsburghDepartment of Infection Biology and Microbiomes, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-3806-0039
Tilmann WeberThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.ORCID http://orcid.org/0000-0002-8260-5120
José Manuel Beltrán-BeleñaCluster of Excellence EXC 2124 Controlling Microbes to Fight Infections, Tübingen, Germany.ORCID http://orcid.org/0000-0002-8553-468X
Heike Brötz-OesterheltGerman Center for Infection Research (DZIF), partner site Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0001-9364-1832
Stephanie GrondCluster of Excellence EXC 2124 Controlling Microbes to Fight Infections, Tübingen, Germany. stephanie.grond@uni-tuebingen.de.ORCID http://orcid.org/0000-0002-7549-4936
Bernhard KrismerDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany. b.krismer@uni-tuebingen.de.ORCID http://orcid.org/0000-0002-9505-8285
Andreas PeschelDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-3209-8626

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39117907
PMCPMC11602706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.